News | RIVM

Information about medicines more accessible to the user

The Medicines Evaluation Board (MEB), the Netherlands Pharmacovigilance Centre (Lareb), the National Institute for Public Health and the Environment (RIVM), and the National Health Care Institute w

Average disease burden highest for invasive pneumococcal disease and influenza

The average annual disease burden for the total Dutch population was highest for invasive pneumococcal disease and influenza.

Active monitoring period for Ebola ends for evacuated aid workers

As 21 days have passed since the two aid workers evacuated from Sierra Leone had unprotected contact with Ebola patients, active monitoring of their health status by the Community Health Service ha

RIVM presents four scenarios on future public health at European Health Forum Gastein

On the first day of the 17th European Health Forum Gastein (EHFG), the Dutch National Institute for Public Health and the Environment (RIVM) organises a workshop on ‘Our health in 2040’.

The two Dutch patients are not infected with Ebola virus

The two patients, who have been admitted to the hospital under suspicion of an Ebola infection, are not infected with the virus.

Patient admitted for Ebola assessment

On 22 September, following the request of the General Practitioner, a patient was transported to the Radboudumc in order to undergo further medical assessment.

Dutch aid workers discharged from hospital

Two repatriated Dutch aid workers were discharged Monday 15 September from Leiden University Medical Center (LUMC) after a 24-hour observation period.

Monitoring system for acceptation of and communication about the National Immunisation Programme

On September 12 2014, RIVM organised the symposium ‘Acceptation of and communication about the National Immunisation Programme’.

Dutch doctors evacuated from Sierra Leone

Two Dutch doctors working for an NGO (the Lion Heart Foundation) will be evacuated from Sierra Leone.

Dutch Health Care Performance Report 2014 published

Every four years, RIVM assesses the quality, accessibility and affordability of the Dutch healthcare system.